722 related articles for article (PubMed ID: 28757253)
21. Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesis.
Matsuura T; Maru Y; Izumiya M; Hoshi D; Kato S; Ochiai M; Hori M; Yamamoto S; Tatsuno K; Imai T; Aburatani H; Nakajima A; Hippo Y
Carcinogenesis; 2020 Jun; 41(4):490-501. PubMed ID: 31233118
[TBL] [Abstract][Full Text] [Related]
22. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
[TBL] [Abstract][Full Text] [Related]
23.
Maddipati R; Norgard RJ; Baslan T; Rathi KS; Zhang A; Saeid A; Higashihara T; Wu F; Kumar A; Annamalai V; Bhattacharya S; Raman P; Adkisson CA; Pitarresi JR; Wengyn MD; Yamazoe T; Li J; Balli D; LaRiviere MJ; Ngo TC; Folkert IW; Millstein ID; Bermeo J; Carpenter EL; McAuliffe JC; Oktay MH; Brekken RA; Lowe SW; Iacobuzio-Donahue CA; Notta F; Stanger BZ
Cancer Discov; 2022 Feb; 12(2):542-561. PubMed ID: 34551968
[TBL] [Abstract][Full Text] [Related]
24. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
25. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer.
Song Y; Washington MK; Crawford HC
Cancer Res; 2010 Mar; 70(5):2115-25. PubMed ID: 20160041
[TBL] [Abstract][Full Text] [Related]
26. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
[TBL] [Abstract][Full Text] [Related]
27. Proteomic Analysis of Metastasis-Specific Biomarkers in Pancreatic Cancer: Galectin-1 Plays an Important Metastatic Role in Pancreatic Cancer.
Tung CL; Lin MW; Hu RY; Chien YC; Liao EC; Lin LH; Chung TW; Wei YS; Tsai YT; Chen HY; Chou HC; Kuo WH; Ko ML; Chang SJ; Lee YR; Chan HL
J Pharm Biomed Anal; 2020 Jul; 186():113300. PubMed ID: 32413824
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological inhibition and genetic knockdown of exchange protein directly activated by cAMP 1 reduce pancreatic cancer metastasis in vivo.
Almahariq M; Chao C; Mei FC; Hellmich MR; Patrikeev I; Motamedi M; Cheng X
Mol Pharmacol; 2015 Feb; 87(2):142-9. PubMed ID: 25385424
[TBL] [Abstract][Full Text] [Related]
29. FOXA2 controls the cis-regulatory networks of pancreatic cancer cells in a differentiation grade-specific manner.
Milan M; Balestrieri C; Alfarano G; Polletti S; Prosperini E; Spaggiari P; Zerbi A; Diaferia GR; Natoli G
EMBO J; 2019 Oct; 38(20):e102161. PubMed ID: 31531882
[TBL] [Abstract][Full Text] [Related]
30. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
31. Organoid models of human and mouse ductal pancreatic cancer.
Boj SF; Hwang CI; Baker LA; Chio II; Engle DD; Corbo V; Jager M; Ponz-Sarvise M; Tiriac H; Spector MS; Gracanin A; Oni T; Yu KH; van Boxtel R; Huch M; Rivera KD; Wilson JP; Feigin ME; Öhlund D; Handly-Santana A; Ardito-Abraham CM; Ludwig M; Elyada E; Alagesan B; Biffi G; Yordanov GN; Delcuze B; Creighton B; Wright K; Park Y; Morsink FH; Molenaar IQ; Borel Rinkes IH; Cuppen E; Hao Y; Jin Y; Nijman IJ; Iacobuzio-Donahue C; Leach SD; Pappin DJ; Hammell M; Klimstra DS; Basturk O; Hruban RH; Offerhaus GJ; Vries RG; Clevers H; Tuveson DA
Cell; 2015 Jan; 160(1-2):324-38. PubMed ID: 25557080
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
33. [Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].
Liang ZY; Wang WZ; Gao J; Wu SF; Zeng X; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):102-6. PubMed ID: 17493384
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
[TBL] [Abstract][Full Text] [Related]
35. COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma.
You N; Li J; Gong Z; Huang X; Wang W; Wang L; Wu K; Zheng L
Mol Carcinog; 2017 Feb; 56(2):607-624. PubMed ID: 27350032
[TBL] [Abstract][Full Text] [Related]
36. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
37. Relating pancreatic ductal adenocarcinoma tumor samples and cell lines using gene expression data in translational research.
Shuaichen L; Guangyi W
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):157-162. PubMed ID: 29729710
[TBL] [Abstract][Full Text] [Related]
38. The TALE homeodomain transcription factor MEIS1 activates the pro-metastatic melanoma cell adhesion molecule Mcam to promote migration of pancreatic cancer cells.
von Burstin J; Bachhuber F; Paul M; Schmid RM; Rustgi AK
Mol Carcinog; 2017 Mar; 56(3):936-944. PubMed ID: 27583552
[TBL] [Abstract][Full Text] [Related]
39. EZH2-shRNA-mediated upregulation of p21waf1/cip1 and its transcriptional enhancers with concomitant downmodulation of mutant p53 in pancreatic ductal adenocarcinoma.
Batchu RB; Qazi AM; Gruzdyn OV; Semaan A; Seward SM; Chamala S; Dhulipala VB; Bouwman DL; Weaver DW; Gruber SA
Surgery; 2013 Oct; 154(4):739-46; discussion 746-7. PubMed ID: 24074410
[TBL] [Abstract][Full Text] [Related]
40. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
